Loading company details...
Beta
Latest Form 4 (Aug 19, 2026): Michael B. Petras Jr. (Executive Chairman): Sale of 294,515 shares, $5.45M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Michael B. Petras Jr., Executive Chairman | Sale | 294,515 | $5.45M |
| Aug 11, 2026 | Michael P. Rutz, President of Sterigenics | Sale | 150,000 | $2.83M |
| Aug 7, 2026 | Jonathan M. Lyons, Sr. Vice President, CFO | Tax Withholding | 11,316 | $203.5K |
| May 28, 2026 | Ann R. Klee | Grant/Award | 14,970 | n/a |
| May 27, 2026 | Alton Shader, Chief Executive Officer | Grant/Award | 375,939 | n/a |
| May 27, 2026 | Richard G. Kyle | Grant/Award | 14,970 | n/a |
| May 27, 2026 | Kenneth D. Krause | Grant/Award | 14,970 | n/a |
| May 27, 2026 | Sean Laurence Cunningham | Grant/Award | 14,970 | n/a |
| May 27, 2026 | Karen Flynn | Grant/Award | 14,970 | n/a |
| May 27, 2026 | James Neary | Grant/Award | 14,970 | n/a |